You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nontuberculous Mycobacterial Infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Expectorated and Induced Sputum and Pharyngeal Swabs for

Completed
  • Myobacterium Infections, Nontuberculous
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Mycobacterium Avium Complex Pulmonary Disease Trial (Minocycline)

    Not yet recruiting
    • Mycobacterium Avium Complex Pulmonary Disease
    • (no location specified)
    May 15, 2023

    Transmission and Acquisition of Nontuberculous Mycobacteria

    Recruiting
    • Nontuberculous Mycobacterial Pulmonary Infection
    • +3 more
    • Epidemiologic investigation
    • Denver, Colorado
      National Jewish Health
    Dec 1, 2023

    Prospective Healthcare-Associated Links in Transmission of

    Enrolling by invitation
    • Cystic Fibrosis
    • Nontuberculous Mycobacterial Pulmonary Infection
      • Denver, Colorado
        National Jewish Health
      Jan 6, 2023

      Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF) Trial in United States (Molgramostim nebulizer solution, PARI

      Terminated
      Has Results
      • Mycobacterium Infections, Nontuberculous
      • Cystic Fibrosis (CF)
      • Molgramostim nebulizer solution
      • PARI eFlow nebulizer system
      • Denver, Colorado
      • +4 more
      Oct 10, 2021

      Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto

      Recruiting
      • Nontuberculous Mycobacterial Lung Disease
      • Nontuberculous Mycobacterium Infection
      • Hypertonic saline
      • +3 more
      • New York, New York
      • +2 more
      Jan 27, 2023

      PK and PD of Antibiotics for Treatment of Mycobacterium

      Not yet recruiting
      • Nontuberculous Mycobacterial Pulmonary Infection
      • Measuring PK and PD indices in patients who receive conventional treatment
      • (no location specified)
      Dec 22, 2022

      Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease Trial in

      Recruiting
      • Mycobacterium Infections, Nontuberculous
      • +3 more
      • Omadacycline Oral Tablet
      • Placebo
      • Birmingham, Alabama
      • +20 more
      Jan 11, 2023

      Mycobacterium Abscessus Infection in Chronic Lung Disease and

      Enrolling by invitation
      • Mycobacterium Abscessus Infection
      • +2 more
      • Appropriate treatment
      • Pathum Wan, Bangkok, Thailand
        King Chulalongkorn Memorial Hospital
      Aug 31, 2022

      Cystic Fibrosis Trial in Aurora (Ethambutol, Rifampin, Azithromycin)

      Completed
      Has Results
      • Cystic Fibrosis
      • Aurora, Colorado
        Children's Hospital Colroado
      Jan 20, 2021

      Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Trial (Placebo, SPR720 500 mg, SPR720 1000 mg)

      Not yet recruiting
      • Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
      • Placebo
      • +2 more
      • (no location specified)
      Aug 9, 2022

      Mycobacterium Infections, Nontuberculous Trial in Australia, United Kingdom (Inhaled molgramostim)

      Completed
      • Mycobacterium Infections, Nontuberculous
      • Inhaled molgramostim
      • Concord, New South Wales, Australia
      • +4 more
      Mar 23, 2021

      Nontuberculous Mycobacterium Infection Trial in Portland, Charleston (gNO)

      Completed
      Has Results
      • Nontuberculous Mycobacterium Infection
      • Portland, Oregon
      • +1 more
      May 17, 2021

      Soluble Programmed Death-1 in Predicting Progression of

      Recruiting
      • Nontuberculous Mycobacterial Lung Disease
        • Taipei, Taiwan
          National Taiwan University Hospital
        Jan 18, 2023

        Nontuberculous Mycobacterial Diseases Trial in Nijmegen (Clofazimine)

        Recruiting
        • Nontuberculous Mycobacterial Diseases
        • Nijmegen, Gelderland, Netherlands
          Radboud university medical center
        Sep 9, 2022

        Nontuberculous Mycobacterial Lung Disease Trial in Shanghai (New regimen(BdqCfzLzd+XY))

        Not yet recruiting
        • Nontuberculous Mycobacterial Lung Disease
        • New regimen(BdqCfzLzd+XY)
        • Shanghai, China
          Shanghai Pulmonary Hospital
        Aug 8, 2022

        Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis, Mycobacterial Pneumonia Trial in Greenslopes (LungFit)

        Recruiting
        • Non-Tuberculous Mycobacterial Pneumonia
        • +4 more
        • LungFit
        • Greenslopes, Queensland, Australia
          Gallipoli Medical Research Foundation
        Dec 24, 2020

        Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

        Active, not recruiting
        • Mycobacterium Infections, Nontuberculous
        • Birmingham, Alabama
        • +110 more
        Jan 23, 2023

        Mycobacterium Infections, Nontuberculous Trial in Saint Louis (Recombinant human interleukin-7)

        Recruiting
        • Mycobacterium Infections, Nontuberculous
        • Recombinant human interleukin-7
        • Saint Louis, Missouri
          Washington University
        Mar 30, 2022

        Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical

        Recruiting
        • Nontuberculous Mycobacterial Lung Disease
          • Charlottesville, Virginia
            University of Virginia, Division of Infectious Disease
          May 16, 2022

          Mycobacterial and Opportunistic Infections in HIV-Negative Thai

          Active, not recruiting
          • Non-Tuberculous Mycobacteria
          • +2 more
            • Taiwan, China
              National Taiwan University
            Aug 18, 2022

            Study of Mycobacterial Infections

            Recruiting
            • Mycobacterium Infections
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 21, 2023

            Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)

            Completed
            Has Results
            • Mycobacterium Infections, Nontuberculous
            • LAI (Liposomal Amikacin for Inhalation) 590 mg
            • (no location specified)
            Apr 22, 2020

            Healthcare-associated Links in Transmission of Nontuberculous

            Recruiting
            • Cystic Fibrosis
            • Nontuberculous Mycobacterium Infection
            • Epidemiologic investigation
            • Denver, Colorado
              National Jewish Health
            Apr 6, 2022

            Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

            Recruiting
            • Mycobacterium Infections, Nontuberculous
            • Birmingham, Alabama
            • +172 more
            Jan 23, 2023